Residency · Residency · Interventional Radiology

Percutaneous Image-Guided Lung Biopsy

Overview

CT-guided percutaneous lung biopsy is the standard method for tissue diagnosis of pulmonary nodules and masses. Options include fine needle aspiration (FNA) and core needle biopsy (CNB). High diagnostic accuracy (>90%) with acceptably low complication rates. Critical for staging, molecular profiling, and treatment planning in lung cancer.

Indications

Solitary pulmonary nodule or mass requiring tissue diagnosis. Multiple pulmonary nodules when tissue diagnosis will change management. Lung mass with high suspicion for malignancy not amenable to bronchoscopic biopsy. Mediastinal or hilar mass accessible percutaneously. Pleural-based mass. Infectious etiology requiring organism identification. Follow-up of indeterminate nodules when PET-CT and clinical context are insufficient.

Contraindications

Absolute

Uncorrectable severe coagulopathy. Inability to cooperate or maintain position (severe cough, agitation). Contralateral pneumonectomy (pneumothorax on the biopsy side would be catastrophic).

Relative

Severe emphysema along needle trajectory. Severe pulmonary hypertension. Bullous disease adjacent to the target. Lesion <1 cm (lower diagnostic yield, higher complication rate). Mechanical ventilation (increased pneumothorax risk). Suspected hydatid cyst or AVM (risk of anaphylaxis or hemorrhage).

Technique

Pre-Procedural Planning

Review prior CT, PET-CT, and any other relevant imaging. Assess lesion size, location, depth, and relationship to fissures, vessels, and airways. Plan patient positioning for shortest, safest needle path: Prone for posterior lesions, supine for anterior, lateral decubitus for lateral. Biopsy side dependent when possible (reduces pneumothorax progression). Assess for emphysema along planned trajectory. Coagulation: INR ≤1.5, platelets ≥50,000; hold anticoagulants per SIR guidelines. Discuss sedation plan (local anesthesia ± moderate sedation).

FNA vs. Core Needle Biopsy

FNA (20-25 gauge): Cytologic specimen. Lower pneumothorax rate. Adequate for carcinoma diagnosis in many cases. Limited for lymphoma, benign diagnoses, and molecular testing. Rapid on-site evaluation (ROSE) by cytopathologist improves diagnostic yield. Core needle biopsy (18-20 gauge): Histologic specimen with tissue architecture. Superior for molecular profiling (PD-L1, EGFR, ALK, ROS1). Better for lymphoma diagnosis and benign disease characterization. Higher diagnostic accuracy overall. Slightly higher complication rate than FNA. Increasingly preferred as standard approach given need for molecular testing. Coaxial technique: outer introducer needle placed near lesion; multiple passes through the coaxial needle without re-puncturing pleura. Reduces pneumothorax risk (single pleural puncture). Allows both FNA and core biopsy through same access.

CT-Guided Procedure

Position patient; planning CT to localize target and plan trajectory. Mark skin entry site; prep and drape. Local anesthesia (lidocaine) from skin to pleura. Advance coaxial introducer needle under intermittent CT guidance. Confirm needle tip at lesion margin. Perform biopsy: FNA: aspiration with rapid passes through the lesion. Core biopsy: automated or semi-automated cutting needle through coaxial introducer. Multiple samples obtained (typically 3-5 cores). Post-biopsy CT to assess for pneumothorax and hemorrhage. If ROSE available: cytopathologist confirms specimen adequacy in real-time.

<image>CT-guided coaxial core needle biopsy of a right upper lobe pulmonary mass showing the coaxial needle positioned within the lesion with the biopsy gun advanced through the introducer</image>

<image>Post-biopsy CT scan showing a small pneumothorax and ground-glass opacity surrounding the biopsy tract representing focal pulmonary hemorrhage</image>

Diagnostic Yield

Overall diagnostic accuracy: 90-95% for malignant lesions. Core biopsy superior to FNA for specific diagnosis (93-97% vs. 85-90%). Factors reducing yield: Lesion size <1 cm (yield drops to 70-85%). Deep location requiring long needle path. Necrotic lesions (sample periphery for viable tissue). Ground-glass lesions (difficult to visualize and target). Air bronchograms within consolidation (may represent benign etiology). Non-diagnostic biopsy: 5-15%; may require repeat biopsy or surgical excision. False-negative rate: 5-10% — non-diagnostic biopsy does not exclude malignancy.

Complications

Pneumothorax

Most common complication: 15-25% incidence. Chest tube or aspiration required in 5-10%. Risk factors: Emphysema along trajectory (strongest risk factor). Smaller lesion size. Greater depth from pleural surface. Crossing fissures. Multiple pleural punctures. Lower lobe location (greater respiratory excursion). Delayed pneumothorax: can occur up to 24 hours post-procedure. Management: Small, asymptomatic: observe with 2-4 hour post-procedure chest radiograph. Expanding or symptomatic: small-bore chest tube (8-14 Fr) or aspiration. Position patient biopsy-side-down after procedure.

Pulmonary Hemorrhage

Parenchymal hemorrhage (ground-glass around tract): common (5-15%), usually self-limited. Hemoptysis: 1-5%; usually minor. Massive hemoptysis: rare (<1%); may require bronchial artery embolization. Risk factors: central lesions near large vessels, pulmonary hypertension, coagulopathy.

Other Complications

Air embolism: rare (<0.1%) but potentially fatal. Prevention: keep needle hub sealed, avoid deep inspiration with open needle. Treatment: left lateral decubitus, Trendelenburg position, supportive care. Chest wall hematoma. Tumor seeding along tract: extremely rare (<0.01%). Hemothorax: rare.

Rapid On-Site Evaluation (ROSE)

Cytopathologist present during procedure to evaluate specimens in real-time. Advantages: Immediate assessment of specimen adequacy. Reduces number of non-diagnostic biopsies. Reduces number of needle passes. Allows redirection if initial samples are non-diagnostic. Limitations: not available at all institutions, adds cost and staffing requirements. Alternative: touch preparations from core biopsy specimens.

Clinical Pearls

The coaxial technique is strongly preferred — it limits pleural punctures to a single pass, reducing pneumothorax risk and allowing multiple samples through the same access. For lesions requiring molecular profiling (NSCLC), core biopsy is essential — FNA alone may not provide sufficient tissue for PD-L1, EGFR, and ALK testing. Always biopsy the periphery of a large mass — the center is often necrotic and yields non-diagnostic material. Position the patient with the biopsy side dependent after the procedure to reduce pneumothorax progression (tamponade effect). For ground-glass opacity nodules, consider using a CT gantry angle that maximizes the solid component in the needle path. Always obtain a post-biopsy CT before the patient leaves the CT table — an expanding pneumothorax may require immediate aspiration. Patients with contralateral pneumonectomy should NEVER undergo percutaneous lung biopsy — a pneumothorax would be immediately life-threatening; use bronchoscopic biopsy instead. A non-diagnostic biopsy (especially for a PET-avid lesion) does not exclude malignancy — discuss with the multidisciplinary team whether repeat biopsy, surgical excision, or close surveillance is appropriate. Air embolism, though rare, is the most immediately dangerous complication — always keep the needle hub sealed and instruct the patient not to take deep breaths with the needle open.

References

• Defined HL, et al. CT-Guided Lung Biopsy: Current Techniques and Pitfalls. RadioGraphics. 2017;37(3):946-962.
• Defined SIR Quality Improvement Guidelines for Percutaneous Needle Biopsy. J Vasc Interv Radiol. 2010;21(7):969-975.
• Defined AM, et al. Core Needle vs. Fine Needle Aspiration Biopsy for Lung Lesions: Systematic Review and Meta-Analysis. Radiology. 2015;276(3):860-869.
• Defined RJ, et al. Pneumothorax Risk Factors in CT-Guided Lung Biopsy. Radiology. 2012;264(2):590-596.
• Defined National Comprehensive Cancer Network. NCCN Guidelines for Non-Small Cell Lung Cancer. Version 3.2024.
• Defined JR, et al. Air Embolism During CT-Guided Lung Biopsy: Incidence and Outcomes. AJR Am J Roentgenol. 2018;210(6):1227-1233.

Read this lecture as Markdown